Dr. Florian Cymer

Switzerland
After his study of Biology with a focus on Molecular Biology and Biophysics at the University of Ulm, Germany, Florian did his PhD and several PostDocs in the field of membrane protein folding & interaction in Freiburg, Mainz and Stockholm. Since 2014 he is working at Roche in Switzerland in the analytics department initially working on therapeutic protein/receptor interactions and later heading a QC group developing and using bioassays during clinical development stages.

His responsibilities are the functional characterization and QC release analytics of different large molecules, especially monoclonals in development and production for Roche Pharma Europe. The techniques used in his lab include cell-based potency assays, ELISAs, surface plasmon resonance and affinity chromatography for process development and product release.

His special focus is on antibody effector functions and how these are modulated by antibody glycans.

Events/Masterclasses Dr. Florian Cymer is currently speaking at

Pharma

Bioassays & Bioanalytical Methods
14 - 16 May 2024
Online Live Stream | 13:30 CEST - 17:30 CEST
This practical Bioassays and Bioanalytical Methods online live training is focused on complex therapeutics, such as Biopharmaceuticals, Biologics and Biosimilars.

Are you interested in a custom-made event with this trainer?

Contact us to Request more information about your custom-made Corporate Learning program.

REQUEST MORE INFORMATION

Dr. Florian Cymer
Job
Switzerland
After his study of Biology with a focus on Molecular Biology and Biophysics at the University of Ulm, Germany, Florian did his PhD and several PostDocs in the field of membrane protein folding & interaction in Freiburg, Mainz and Stockholm. Since 2014 he is working at Roche in Switzerland in the analytics department initially working on therapeutic protein/receptor interactions and later heading a QC group developing and using bioassays during clinical development stages.

His responsibilities are the functional characterization and QC release analytics of different large molecules, especially monoclonals in development and production for Roche Pharma Europe. The techniques used in his lab include cell-based potency assays, ELISAs, surface plasmon resonance and affinity chromatography for process development and product release.

His special focus is on antibody effector functions and how these are modulated by antibody glycans.
Dr. Florian Cymer
Description